20-36173889-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_012156.2(EPB41L1):c.112G>A(p.Gly38Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012156.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPB41L1 | NM_012156.2 | c.112G>A | p.Gly38Ser | missense_variant | 2/22 | ENST00000338074.7 | NP_036288.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPB41L1 | ENST00000338074.7 | c.112G>A | p.Gly38Ser | missense_variant | 2/22 | 1 | NM_012156.2 | ENSP00000337168 | P5 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000480 AC: 12AN: 250046Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135318
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461708Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727166
GnomAD4 genome AF: 0.000171 AC: 26AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74414
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.112G>A (p.G38S) alteration is located in exon 2 (coding exon 1) of the EPB41L1 gene. This alteration results from a G to A substitution at nucleotide position 112, causing the glycine (G) at amino acid position 38 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
EPB41L1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 28, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at